• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体驱动转录中氨基末端分隔增强子的结构和功能分析。

Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription.

机构信息

The University of Texas Medical School at Houston, TX 77030, USA.

出版信息

Biochem J. 2010 Apr 14;427(3):499-511. doi: 10.1042/BJ20091631.

DOI:10.1042/BJ20091631
PMID:20163360
Abstract

We previously demonstrated that the Groucho protein AES (amino-terminal enhancer of split) functions as a co-repressor of the AR (androgen receptor). It physically interacts with the N-terminal domain of AR and inhibits AR-driven transcription, but the molecular mechanism of its action remained unclear. In the present paper we report that the AES protein contains one inhibitory domain, and one positive and one negative regulatory domain. The negative regulatory domain inhibits AES dimerization and AES-mediated inhibition of AR-driven transcription through an interaction with the inhibitory domain. The positive regulatory domain blocked this interaction and relieved the inhibitory effect. In addition, we discovered mechanisms by which AES regulates AR transcriptional activity, which included disruption of the interaction between the AR N-terminal and C-terminal domains, and inhibition of AR-DNA interaction. Although AES broadly inhibited the activity of androgen-dependent luciferase reporters in a transient transfection assay, it selectively regulated the expression of endogenous androgen-dependent genes in prostate cancer cells.

摘要

我们之前的研究表明,Groucho 蛋白 AES(split 的氨基末端增强子)作为 AR(雄激素受体)的共抑制因子发挥作用。它与 AR 的 N 端结构域相互作用,抑制 AR 驱动的转录,但其作用的分子机制尚不清楚。在本文中,我们报告 AES 蛋白含有一个抑制结构域,一个正调节结构域和一个负调节结构域。负调节结构域通过与抑制结构域相互作用,抑制 AES 二聚化和 AES 介导的 AR 驱动转录抑制。正调节结构域阻断了这种相互作用,从而解除了抑制作用。此外,我们发现 AES 调节 AR 转录活性的机制,包括破坏 AR N 端和 C 端结构域之间的相互作用,以及抑制 AR-DNA 相互作用。虽然 AES 在瞬时转染试验中广泛抑制雄激素依赖性荧光素酶报告基因的活性,但它选择性地调节前列腺癌细胞中内源性雄激素依赖性基因的表达。

相似文献

1
Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription.雄激素受体驱动转录中氨基末端分隔增强子的结构和功能分析。
Biochem J. 2010 Apr 14;427(3):499-511. doi: 10.1042/BJ20091631.
2
Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split.通过分裂蛋白氨基末端增强子抑制雄激素受体介导的转录
Mol Cell Biol. 2001 Jul;21(14):4614-25. doi: 10.1128/MCB.21.14.4614-4625.2001.
3
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.TBLR1 作为雄激素受体 (AR) 共激活因子,选择性地激活 AR 靶基因,抑制前列腺癌生长。
Endocr Relat Cancer. 2014 Jan 16;21(1):127-42. doi: 10.1530/ERC-13-0293. Print 2014 Feb.
4
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.Gli2 共激活野生型和天然截断雄激素受体的决定因素。
Prostate. 2014 Oct;74(14):1400-10. doi: 10.1002/pros.22855. Epub 2014 Aug 11.
5
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.FOXP1是一种雄激素反应性转录因子,它在前列腺癌细胞中负向调节雄激素受体信号传导。
Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.
6
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.HEYL 通过抑制雄激素受体活性,成为 Notch 效应因子家族 hairy/Enhancer-of-split 相关蛋白中的第三个成员。
J Biol Chem. 2011 May 20;286(20):17796-808. doi: 10.1074/jbc.M110.198655. Epub 2011 Mar 17.
7
Negative modulation of androgen receptor transcriptional activity by Daxx.Daxx对雄激素受体转录活性的负向调节
Mol Cell Biol. 2004 Dec;24(24):10529-41. doi: 10.1128/MCB.24.24.10529-10541.2004.
8
The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription.组蛋白甲基转移酶NSD2可增强雄激素受体介导的转录。
FEBS Lett. 2009 Jun 18;583(12):1880-6. doi: 10.1016/j.febslet.2009.05.038. Epub 2009 May 28.
9
The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.共抑制因子类视黄醇和甲状腺激素受体沉默介质以及核受体共抑制因子参与雄激素受体对激动剂和拮抗剂调节的转录过程。
Mol Endocrinol. 2006 May;20(5):1048-60. doi: 10.1210/me.2005-0324. Epub 2005 Dec 22.
10
The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.CCAAT增强子结合蛋白α负向调节前列腺癌细胞中雄激素受体的反式激活。
Mol Endocrinol. 2006 May;20(5):984-95. doi: 10.1210/me.2005-0240. Epub 2006 Feb 2.

引用本文的文献

1
Roles of transducin-like enhancer of split (TLE) family proteins in tumorigenesis and immune regulation.分裂样转导素增强子(TLE)家族蛋白在肿瘤发生和免疫调节中的作用。
Front Cell Dev Biol. 2022 Nov 11;10:1010639. doi: 10.3389/fcell.2022.1010639. eCollection 2022.
2
Repression by the TOPLESS corepressor requires association with the core mediator complex.TOPLESS 核心抑制因子的抑制作用需要与核心中介复合物结合。
Elife. 2021 Jun 2;10:e66739. doi: 10.7554/eLife.66739.
3
The function of tcf3 in medaka embryos: efficient knockdown with pePNAs.
tcf3 在胚胎中的功能:pePNAs 的高效敲低。
BMC Biotechnol. 2018 Jan 9;18(1):1. doi: 10.1186/s12896-017-0411-0.
4
Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.分裂基因AES的氨基末端增强子编码一种前列腺癌的肿瘤和转移抑制因子。
Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.
5
GRG5/AES interacts with T-cell factor 4 (TCF4) and downregulates Wnt signaling in human cells and zebrafish embryos.GRG5/AES 与人 T 细胞因子 4(TCF4)相互作用,下调人细胞和斑马鱼胚胎中的 Wnt 信号通路。
PLoS One. 2013 Jul 1;8(7):e67694. doi: 10.1371/journal.pone.0067694. Print 2013.
6
AES/GRG5: more than just a dominant-negative TLE/GRG family member.AES/GRG5:不仅仅是一个显性负性的 TLE/GRG 家族成员。
Dev Dyn. 2010 Nov;239(11):2795-805. doi: 10.1002/dvdy.22439.